Showing results (431-440 of 1,513) with videos related to

Sort By:
Pageof 152
Scientific Reports|March 23, 2025
VRd vs. VPd as induction therapy in high risk newly diagnosed multiple myelomaChun Yan Li, Long Zhong, Dan Gui Chen, et al.
Huan Jing Ke Xue= Huanjing Kexue|December 20, 2019
[Intensified Electrosorption of Pb2+ by 2,6-diaminoanthraquinone/Graphene Composite Electrode]Sheng-Yao Jin, Yang Xiang, Jun-Yu Zhang, et al.
Fitoterapia|April 16, 2023
The first phytochemical investigation of Artemisia nujianensis: Eight new guaianolides and their anti-inflammatory activityShan Yu, Chunping Tang, Chang-Qiang Ke, et al.
Blood|June 25, 2010
Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral toleranceTomohiro Fukaya, Hideaki Takagi, Yumiko Sato, et al.
Cancer Research|February 12, 2005
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunityFumiya Hirano, Katsumi Kaneko, Hideto Tamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitisMonique Lafon, Françoise Mégret, Sven G Meuth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic SitesHarriet M Kluger, Christopher R Zito, Meaghan L Barr, et al.
Nature Communications|February 12, 2021
Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapyYing Li, Yanni Cong, Mingming Jia, et al.
Oncoimmunology|February 5, 2019
CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancersYu Tian, Yi Sun, Fan Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapyJanis M Taube, Alison Klein, Julie R Brahmer, et al.
Pageof 152